Bioinks for 3D Bioprinting: an Overview
Overview
Pharmacology
Affiliations
Bioprinting is an emerging technology with various applications in making functional tissue constructs to replace injured or diseased tissues. It is a relatively new approach that provides high reproducibility and precise control over the fabricated constructs in an automated manner, potentially enabling high-throughput production. During the bioprinting process, a solution of a biomaterial or a mixture of several biomaterials in the hydrogel form, usually encapsulating the desired cell types, termed the bioink, is used for creating tissue constructs. This bioink can be cross-linked or stabilized during or immediately after bioprinting to generate the final shape, structure, and architecture of the designed construct. Bioinks may be made from natural or synthetic biomaterials alone, or a combination of the two as hybrid materials. In certain cases, cell aggregates without any additional biomaterials can also be adopted for use as a bioink for bioprinting processes. An ideal bioink should possess proper mechanical, rheological, and biological properties of the target tissues, which are essential to ensure correct functionality of the bioprinted tissues and organs. In this review, we provide an in-depth discussion of the different bioinks currently employed for bioprinting, and outline some future perspectives in their further development.
Hydrogels for Cardiac Tissue Regeneration: Current and Future Developments.
Holme S, Richardson S, Bella J, Pinali C Int J Mol Sci. 2025; 26(5).
PMID: 40076929 PMC: 11900105. DOI: 10.3390/ijms26052309.
Unlocking Ectoine's Postbiotic Therapeutic Promise: Mechanisms, Applications, and Future Directions.
Xingrong L, Gorish B, Qaria M, Hussain A, Abdelmula W, Zhu D Probiotics Antimicrob Proteins. 2025; .
PMID: 40072821 DOI: 10.1007/s12602-025-10506-5.
Microgel-based bioink for extrusion-based 3D bioprinting and its applications in tissue engineering.
Iyer K, Bao L, Zhai J, Jayachandran A, Luwor R, Li J Bioact Mater. 2025; 48:273-293.
PMID: 40060146 PMC: 11889356. DOI: 10.1016/j.bioactmat.2025.02.003.
Heterogeneous and Composite Bioinks for 3D-Bioprinting of Complex Tissue.
Rasouli R, Sweeney C, Frampton J Biomed Mater Devices. 2025; 3(1):108-126.
PMID: 40028238 PMC: 11868245. DOI: 10.1007/s44174-024-00171-7.
Hydrogels and Nanogels: Pioneering the Future of Advanced Drug Delivery Systems.
Delgado-Pujol E, Martinez G, Casado-Jurado D, Vazquez J, Leon-Barberena J, Rodriguez-Lucena D Pharmaceutics. 2025; 17(2).
PMID: 40006582 PMC: 11859140. DOI: 10.3390/pharmaceutics17020215.